Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › THREONINE166 and SERINE189 of rubicon run domain as LRRK2 kinase inhibition target sites

THREONINE166 and SERINE189 of rubicon run domain as LRRK2 kinase inhibition target sites

US Patent 12319733 · Granted Jun 3, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Efficient search query auto-completion from unstructured text2025